Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mahler

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
Immunologic Research|June 12, 2021
Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodiesMichael Mahler, Grace Kim, Fabrece Roup, et al.
RMD Open|April 10, 2024
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody testAndrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, et al.
Plos One|May 3, 2013
An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptorAstrid Behnert, Marvin J Fritzler, Beina Teng, et al.
Arthritis Research & Therapy|April 17, 2013
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assayMichael Mahler, Cristina Gascon, Sima Patel, et al.
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
Journal of Immunology Research|April 18, 2014
Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologiesLucile Musset, Makoto Miyara, Olivier Benveniste, et al.
Biomedicines|December 22, 2020
Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin AntibodiesMassimo Radin, Irene Cecchi, Silvia Grazietta Foddai, et al.
Antibodies (Basel, Switzerland)|February 22, 2023
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and PolymyositisLinda Di Pietro, Fabio Chiccoli, Lorenzo Salvati, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2020
Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid ArthritisAndrea Di Matteo, Kulveer Mankia, Laurence Duquenne, et al.
Clinical Chemistry and Laboratory Medicine|February 28, 2021
Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammationMaria Infantino, Mariangela Manfredi, Roger Albesa, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
Immunologic Research|June 12, 2021
Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodiesMichael Mahler, Grace Kim, Fabrece Roup, et al.
RMD Open|April 10, 2024
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody testAndrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, et al.
Plos One|May 3, 2013
An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptorAstrid Behnert, Marvin J Fritzler, Beina Teng, et al.
Arthritis Research & Therapy|April 17, 2013
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assayMichael Mahler, Cristina Gascon, Sima Patel, et al.
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
Journal of Immunology Research|April 18, 2014
Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologiesLucile Musset, Makoto Miyara, Olivier Benveniste, et al.
Biomedicines|December 22, 2020
Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin AntibodiesMassimo Radin, Irene Cecchi, Silvia Grazietta Foddai, et al.
Antibodies (Basel, Switzerland)|February 22, 2023
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and PolymyositisLinda Di Pietro, Fabio Chiccoli, Lorenzo Salvati, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2020
Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid ArthritisAndrea Di Matteo, Kulveer Mankia, Laurence Duquenne, et al.
Clinical Chemistry and Laboratory Medicine|February 28, 2021
Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammationMaria Infantino, Mariangela Manfredi, Roger Albesa, et al.
Pageof 21